Comparison of granisetron plus dexamethasone versus an antiemetic cocktail containing midazolam and diphenhydramine for chemotherapy induced nausea and vomiting in children

Indian Journal of Medical and Paediatric Oncology

Volumn 34, Issue 4, 2013, Pages 270-273

  Emir, Suna ^a   Erturgut, Pinar ^a   Vidinlisan, Sadi ^a  

^a SB Ankara Children's Hematology Oncology Research Hospital   (Turkey)

Author keywords

Antiemetics; Cancer; Chemotherapy; Children; Nausea; Vomiting

Indexed keywords

CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; GRANISETRON; MIDAZOLAM;

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ARTICLE; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONSCIOUSNESS DISORDER; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; EWING SARCOMA; FEMALE; GERM CELL TUMOR; HEADACHE; HEPATOBLASTOMA; HUMAN; HYPOTENSION; MALE; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOSARCOMA; SCHOOL CHILD; SEDATION; TREATMENT RESPONSE;

EID: 84893228542     PISSN: 09715851     EISSN: 09752129     Source Type: Journal    
DOI: 10.4103/0971-5851.125243     Document Type: Article

References (10)

1. Dewan P, Singhal S, Harit D. Management of chemotherapyinduced nausea and vomiting. Indian Pediatr 2010;47:149-55.
2. Jordan K, Roila F, Molassiotis A, Maranzano E, Clark- Snow RA, Feyer P, et al. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009. Support Care Cancer 2011;19 Suppl 1:S37-42.
3. Phillips RS, Gopaul S, Gibson F, Houghton E, Craig JV, Light K, et al. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood. Cochrane Database Syst Rev 2010: Sep 8; (9): CD007786.
4. Berrak SG, Ozdemir N, Bakirci N, Turkkan E, Canpolat C, Beker B, et al. A double-blind, crossover, randomized dosecomparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy. Support Care Cancer 2007;15:1163-8.
5. Schmoll HJ, Aapro MS, Poli-Bigelli S, Kim HK, Park K, Jordan K, et al. Comparison of an aprepitant regimen with a multipleday ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment. Ann Oncol 2006;17:1000-6.
6. Gore L, Chawla S, Petrilli A, Hemenway M, Schissel D, Chua V, et al. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: A randomized, double-blind, placebo-controlled study of efficacy and tolerability. Pediatr Blood Cancer 2009;52:242-7.
7. Mandalà M, Cremonesi M, Rocca A, Cazzaniga M, Ferretti G, Di Cosimo S, et al. Midazolam for acute emesis refractory to dexamethasone and granisetron after highly emetogenic chemotherapy: A phase II study. Support Care Cancer 2005;13:375-80.
8. Jordan K, Schmoll HJ, Aapro MS. Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 2007;61:162-75.
9. Grunberg SM. Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: Dosing, efficacy, and tolerability analysis. Ann Oncol 2007;18:233-40.
10. Dix S, Cord M, Howard S, Coon J, Belt R, Geller R. Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy. Bone Marrow Transplant 1999;24:561-6.